Pathophysiology of Alcohol-Induced Pancreatitis

Pancreas

Volumn 27, Issue 4, 2003, Pages 291-296

  Lerch, Markus M ^a   Albrecht, Elke ^b   Ruthenbürger, Manuel ^a   Mayerle, Julia ^a   Halangk, Walter ^c   Krüger, Burkhard ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Cholecystokinin; Ethanol; Serine proteases; Trypsinogen; Trypsinogen activation peptide

Indexed keywords

ALCOHOL; CATHEPSIN B; CHOLECYSTOKININ; SERINE PROTEINASE; TRYPSIN; TRYPSINOGEN; TRYPSINOGEN ACTIVATION PEPTIDE;

ACINAR CELL; ALCOHOLIC PANCREATITIS; ARTICLE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME ACTIVATION; HUMAN; PANCREATITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ACETALDEHYDE; CATHEPSIN B; ENZYME ACTIVATION; HUMANS; PANCREAS; PANCREATITIS, ALCOHOLIC; TRYPSIN;

EID: 0242317848     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200311000-00003     Document Type: Article

References (64)

1. Chiari H. Über die Selbstverdauung des menschlichen Pankreas. Z Heilk. 1896;17:69-96.
2. Gorelick FS, Adler G, Kem HF. Cerulein-induced pancreatitis. In: Go VLW, DiMagno EP, Gardner, et al, eds. The pancreas: biology, pathobiology, and disease. New York: Raven Press, 1993:501-526
3. Lerch MM, Adler G. Experimental pancreatitis. Curr Opin Gastroenterol. 1993;9:752-759.
4. Lerch MM, Adler G. Experimental animal models of acute pancreatitis. Int J Pancreatol 1994;15:159-170.
5. Kloeppel G, Dreyer T, Willemer S, et al. Human acute pancreatitis: its pathogenesis in the light of immunocytochemical and ultrastructural findings in acinar cells. Virchows Arch. 1986;409:791-803.
6. Foulis AK. Histological evidence of initiating factors in acute necrotizing pancreatitis in man. J Clin Pathol. 1980;33:1125-1131.
7. Lerch MM, Saluja AK, Dawra R, et al. Acute necrotising pancreatitis in the opossum: earliest morphologic changes involve acinar cells. Gastroenterology. 1992;103:205-213.
8. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation on the cationic trypsinogen gene. Nat Genet. 1996;14:141-145.
9. Whitcomb DC. Genes means pancreatitis. Gut. 1999;44:150.
10. Rinderknecht H. Activation of pancreatic zymogens. Normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation. Dig Dis Sci. 1986;31:314-321.
11. Bialek R, Willemer S, Arnold R, et al. Evidence of intracellular activation of serine proteases in acute cerulein-induced pancreatitis in rats. Scand J Gastroenterol. 1991;26:190-196.
12. Luthen R, Niederau C, Grendell JH. Intrapancreatic zymogen activation and levels of ATP and glutathione during caerulein pancreatitis in rats. Am J Physiol 1995;268:G592-G604.
13. Schmidt J, Fernandez-del Castillo C, Rattner DW, et al. Trypsinogen-activation peptides in experimental rat pancreatitis: prognostic implications and histopathologic correlates. Gastroenterology. 1992;103:1009-1016.
14. Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med. 1996;335:919-923.
15. Tympner F, Rosch W. Effect of secretin and gabexate-mesilate (synthetic protease inhibitor) on serum amylase level after ERCP. Z Gastroenterol. 1982;20:688-693.
16. Lasson A, Ohlsson K. Protease inhibitors in acute pancreatitis: correlation between biochemical changes and clinical course. Scand J Gastroenterol. 1984;19:779-786.
17. Niederau C, Grendell JH. Intracellular vacuoles in experimental acute pancreatitis in rats and mice are an acidified compartment. J Clin Invest. 1988;81:229-236.
18. Gorry MC, Gabbaizedeh D, Furey W, et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology. 1997;113:1063-1068.
19. Varallyay E, Pal G, Patthy A, et al. Two mutations in rat trypsin confer resistance against autolysis. Biochem Biophys Res Commun. 1998;243:56-60.
20. Appelros S, Thim L, Borgstorm A. Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis. Gut. 1998;42:97-102.
21. Gudgeon AM, Heath DI, Hurley P, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet. 1990;335:4-8.
22. Mithofer K, Femandez-del Castillo C, Rattner D, et al. Subeellular kinetic of early trypsinogen activation in acute rodent pancreatitis. Am J Physiol. 1998;274:G71-G79.
23. Gukowskaya AS, Zaninovic V, Lam VH, et al, Neutrophils regulate trypsin activation in cerulein pancreatitis. Gastroenterology. 1999;116:A1128.
24. Buchler M, Malfertheiner P, Uhl W, et al. Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology. 1993;104:1165-1170.
25. Hurley PR, Cook A, Jehanli A, et al. Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activadon peptides (TAP). J Immunol Methods. 1988;111:195-203.
26. Neoptolemos JP, Kemppainen EA, Mayer JM, et al. A multicentre study of early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide. Lancet. 2000;355:1955-1960.
27. Teich N, Mossner J, Keim V. Mutations of the cationic trypsinogen in hereditary pancreatitis. Hum Mutat. 1998;12:39-43.
28. Gorelick F, Matovcik L. Lysosomal enzymes and pancreatitis. Gastroenterology. 1995;109::620-625.
29. Steer ML, Meldolesi J. The cell biology of experimental pancreatitis. N Engl J Med. 1987;316:144-150.
30. Figarella C, Miszczuk-Jamska B, Barrett A. Possible lysosomal activation of pancreatic zymogens: activation of both human trypsinogens by cathepsin B and spontaneous acid activation of human trypsinogen-1. Biol Chem Hoppe-Seyler. 1988;369:293-298.
31. Greenbaum LA, Hirshkowitz A. Endogenous cathepsin activates trypsinogen in extracts of dog pancreas. Proc Soc Exp Biol Med. 1961;107:74-76.
32. Saluja A, Sadamitsu H, Saluja M, et al. Subcellular redistribution of lysosomal enzymes during caerulein-induced pancreatitis. Am J Physiol. 1987;253:G508-G516.
33. Watanabe O, Baccino FM, Steer ML, et al. Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol. 1984;246:G457-G467.
34. Tooze J, Hollinshead M, Hensel G, et al. Regulated secretion of mature cathepsin B from rat exocrine pancreatic cells. Eur J Cell Biol. 1991;56:187-200.
35. Willemer S, Bialek R, Adler G. Localization of lysosomal and digestive enzymes in cytoplasmic vacuoles in caerulein-pancreatitis. Histochemistry. 1990;94:161-170.
36. Lerch MM, Saluja AK, Dawra R, et al. The effect of chloroquine administration on two experimental models of acute pancreatitis. Gastroenterology. 1993;104:1768-1779.
37. Steer ML, Saluja AK. Experimental acute pancreatitis: studies of the early events that lead to cell injury. In: Go VLW, DiMagno EP, Gardner, et al, eds. The pancreas: biology, pathobiology, and disease. New York: Raven Press, 1993:489-500.
38. Leach SD, Modlin IM, Scheele GA, et al. Intracellular activation of digestive zymogens in rat pancreatic acini. Stimulation by high does of cholecystokinin. J Clin Invest. 1991;87:362-366.
39. Saluja AK, Donovan EA, Yamanaka K, et al. Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology. 1997;113:304-310.
40. Gorelick FS, Modlin IM, Leach SD, et al. Intracellular proteolysis of pancreatic zymogens. Yale J Biol Med. 1992;65:407-420.
41. Klonowski-Stumpe H, Luthen C, Han B, et al. Inhibition of cathepsin B does not affect the intracellular activation of trypsinogen by cerulein hyperstimulation in isolated rat pancreatic acinar cells. Pancreas. 1998;16:96-101.
42. Halangk W, Lerch MM, Brandt-Nedelev B, et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest. 2000;106:773-781.
43. Hakansson HO, Borgstrom A, Ohlsson K. Porcine pancreatic cationic pro-elastase. Studies on the activation, turnover and interaction with plasma proteinase inhibitors. Biol Chem Hoppe Seyler. 1991;372:465-472.
44. Kukor Z, Mayerle J, Krüger B, et al. Presence ofcathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. J Biol Chem. 2002;277:21389-21396.
45. Teich N, Ockenga J, Hoffmeister A, et al. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology. 2000;119:461-465.
46. Sahin-Tóth M, Tóth M. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. Biochem Biophys Res Commun. 2000;278:286-289.
47. Sahin-Tóth M. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J Biol Chem. 2000;275:22750-22755.
48. Szilágyi L, Kénesi E, Katona G, et al. Comparative in vitro studies on native and recombinant human cationic trypsins: cathepsin B is a possible pathological activator of trypsinogen in pancreatitis. J Biol Chem. 2001;276:24574-24580.
49. Krüger B, Albrecht E, Lerch MM. The role of intracellular calcium signaling in premature protease activation and the onset of pancreatitis. Am J Pathol. 2000;157:43-50.
50. Krüger B, Weber IA, Albrecht E, et al. Effect of hyperthermia on premature intracellular trypsinogen activation in the exocrine pancreas. Biochem Biophys Res Comm. 2001;282:159-165.
51. Scriver CR. Mutation analysis in metabolic (and other genetic) disease: how soon, how useful. Eur J Pediatr 2000;159(suppl 3):243-245.
52. Witt H, Luck W, Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology. 1999;117:7-10.
53. Ferec C, Raguenes O, Salomon R, et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet. 1999;36:228-232.
54. Gorry MC, Gabbaizedeh D, Furey W, et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology. 1997;113:1063-1068.
55. Halangk W, Krüger B, Ruthenbürger M, et al., Trypsin activity is not involved in premature, intrapancreatic trypsinogen activation. Am J Physiol Gastrointest Liver Physiol. 2002;282:G367-G374.
56. Lerch MM, Gorelick FS. Trypsinogen activation in acute pancreatitis. Med Clin North Am. 2000;84:549-563.
57. Simon P, Weiss FU, Sahin-Toth M, et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 → Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem. 2002;277:5404-5410.
58. Katz M, Carangelo R, Miller LJ, et al. Effect of ethanol on cholecystokinin-stimulated zymogen conversion in pancreatic acinar cells. Am J Physiol. 1996;270: G171-G175.
59. Saluja A, Maitre N, Rünzi M, et al. Ethanol induced increase in plasma cholecystokinin (CCK) level is mediated by the release of a CCK-releasing peptide into the duodenum. J Clin Invest. 1997;99:506-512.
60. Pandol SJ, Periskic S, Gukovsky I, et al. Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology. 1999;117:706-716.
61. Ponnappa BC, Marciniak R, Schneider T, et al. Ethanol consumption and susceptibility of the pancreas to cerulein-induced pancreatitis. Pancreas. 1997;14:150-157.
62. Ramo O. Antecedent long term ethanol consumption in combination with different diets alters the severity of experimental acute pancreatitis in rats. Gut. 1987;28:64-69.
63. Siech M, Weber H, Letko G, et al. Similar morphological and intracellular biochemical changes in alcoholic acute pancreatitis and ischemic acute pancreatitis in rats. Pancreas. 1999;14:32-38.
64. Lu Z, Kame S, Kolodecik T, et al. Alcohols enhance caerulein-induced zymogen activation in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol. 2002;282:G501-G507.